Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 279: | Line 279: | ||
[https://www.science.org/content/article/first-malaria-vaccine-slashes-early-childhood-deaths by Meredith Wadman 24/10/23 Science] | [https://www.science.org/content/article/first-malaria-vaccine-slashes-early-childhood-deaths by Meredith Wadman 24/10/23 Science] | ||
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. | In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. | ||
=====Zambia launches malaria vaccine to protect over half million children===== | |||
[https://www.gavi.org/news/media-room/zambia-launches-malaria-vaccine-protect-over-half-million-children by Gavi 27/10/25] | |||
Lusaka, Zambia, 27 October 2025 – The Government of the Republic of Zambia, through the Ministry of Health, today officially launched the malaria vaccine R21/Matrix-M,as part of its Expanded Programme on Immunisation (EPI), marking a historic milestone in the country’s fight against malaria. Over 500,000 children aged 6–8 months will be vaccinated in the months following the launch. | |||
